Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Pepcid AC

This article was originally published in The Tan Sheet

Executive Summary

Pepcid AC: Recent promotional flier targeting health professionals touts "onset of relief within 15 to 30 minutes." The flier states that Pepcid AC is "still controlling acid up to 12 hours after dosing," noting in fine print that the figure is "based on nocturnal acid control studies." The tri-fold brochure, picturing a pizza on the front, says the product is: "fast acting -- relief begins in just 15 to 30 minutes"; "longer lasting than antacids -- controls acid up to 12 hours, so patients can sleep through the night"; "safe -- no drug interaction warnings"; and "cost effective -- costs no more than leading antacids on a daily basis." The piece is part of ongoing targeted mailing campaign J&J/Merck has conducted since the launch of the H2 antagonist...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel